TAYLOR TODD: Open Payments
NPI 1831549906 · CASTLE ROCK, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 20 payments from 8 companies in 2025. Trend: 2023 $719 · 2024 $2,136 · 2025 $589
Food & beverage: $589
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 3 | $210 |
| Novartis Pharmaceuticals Corporation | 2 | $116 |
| UCB, Inc. | 3 | $91 |
| Incyte Corporation | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 1 | $54 |
| Organon LLC | 6 | $22 |
| ABBVIE INC. | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $15 |
Products named: Zoryve, Bimzelx, COSENTYX, OPZELURA, Sotyktu, SKYRIZI, NEMLUVIO.
Industry payments across CO — which companies pay providers there.
